Abcam Plc (LON:ABC)‘s stock had its “hold” rating reiterated by investment analysts at Peel Hunt in a research report issued to clients and investors on Friday. They currently have a GBX 750 ($9.74) price objective on the stock. Peel Hunt’s target price would suggest a potential downside of 29.71% from the company’s previous close.

A number of other analysts also recently weighed in on the stock. Panmure Gordon reissued a “sell” rating on shares of Abcam Plc in a research report on Thursday, July 27th. Numis Securities Ltd reissued an “add” rating and set a GBX 1,116 ($14.49) target price on shares of Abcam Plc in a research report on Thursday, July 27th. Berenberg Bank assumed coverage on shares of Abcam Plc in a research report on Tuesday, June 27th. They set a “buy” rating and a GBX 1,100 ($14.28) target price for the company. Finally, Stifel Nicolaus reissued a “hold” rating and set a GBX 890 ($11.55) target price on shares of Abcam Plc in a research report on Tuesday, May 2nd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of GBX 900 ($11.68).

Shares of Abcam Plc (LON:ABC) traded down 1.30% during midday trading on Friday, hitting GBX 1067.00. 158,197 shares of the stock traded hands. The firm’s 50-day moving average is GBX 1,004.72 and its 200 day moving average is GBX 924.88. The company’s market capitalization is GBX 2.16 billion. Abcam Plc has a 52 week low of GBX 714.00 and a 52 week high of GBX 1,090.00.

WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at

In other Abcam Plc news, insider Mara G. Aspinall purchased 2,700 shares of the business’s stock in a transaction on Monday, June 5th. The shares were purchased at an average cost of GBX 979 ($12.71) per share, for a total transaction of £26,433 ($34,315.20).

About Abcam Plc

Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.

Analyst Recommendations for Abcam Plc (LON:ABC)

Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with's FREE daily email newsletter.